Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing

Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing

Colorectal cancer (CRC) is the third most common cancer in the world. Despite improvement in standardized screening methods and the development of promising therapies, the 5-year survival rates are as low as 10% in the metastatic setting. The increasing life expectancy of the general population, hig...

Full description

Bibliographic Details
Main Authors: Talal El Zarif, Marcel Yibirin, Diana De Oliveira-Gomes, Marc Machaalani, Rashad Nawfal, Gianfranco Bittar, Hisham F. Bahmad, Nizar Bitar
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
colorectal cancer
therapy resistance
drug repurposing
in silico drug screens
Online Access:https://www.mdpi.com/2072-6694/14/9/2105

Internet

https://www.mdpi.com/2072-6694/14/9/2105

Similar Items